Selected research
Industry Research
Diagnostic Radioisotopes Industry Research Report 2026
Market perspective
The global Diagnostic Radioisotopes market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Diagnostic Radioisotopes is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Diagnostic Radioisotopes is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Diagnostic Radioisotopes is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Diagnostic Radioisotopes include China Isotope & Radiation, Novartis, Eli Lilly, Dongcheng, SIEMENS, Lantheus, Jubilant Pharma, GE Healthcare and Curium Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Diagnostic Radioisotopes market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Diagnostic Radioisotopes Market by Company
China Isotope & Radiation
Novartis
Eli Lilly
Dongcheng
SIEMENS
Lantheus
Jubilant Pharma
GE Healthcare
Curium Pharma
Cardinal Health
Bracco Imaging
Diagnostic Radioisotopes Segment by Type
Tc-99m
F-18
Other
Diagnostic Radioisotopes Segment by Application
Oncology
Cardiology
Other
Diagnostic Radioisotopes Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diagnostic Radioisotopes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diagnostic Radioisotopes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diagnostic Radioisotopes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Diagnostic Radioisotopes manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Diagnostic Radioisotopes by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Diagnostic Radioisotopes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Tc-99m
- F-18
- Other
Applications
- Oncology
- Cardiology
- Other
Companies covered
- China Isotope & Radiation
- Novartis
- Eli Lilly
- Dongcheng
- SIEMENS
- Lantheus
- Jubilant Pharma
- GE Healthcare
- Curium Pharma
- Cardinal Health
- Bracco Imaging
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Diagnostic Radioisotopes Market Size (2021-2032)
- 2.2.2 Global Diagnostic Radioisotopes Sales (2021-2032)
- 2.2.3 Global Diagnostic Radioisotopes Market Average Price (2021-2032)
- 2.3 Diagnostic Radioisotopes by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Tc-99m
- 2.3.3 F-18
- 2.3.4 Other
- 2.4 Diagnostic Radioisotopes by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Oncology
- 2.4.3 Cardiology
- 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Diagnostic Radioisotopes Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Diagnostic Radioisotopes Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Diagnostic Radioisotopes Revenue of Manufacturers (2021-2026)
- 3.4 Global Diagnostic Radioisotopes Average Price by Manufacturers (2021-2026)
- 3.5 Global Diagnostic Radioisotopes Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Diagnostic Radioisotopes, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Diagnostic Radioisotopes, Product Type & Application
- 3.8 Global Manufacturers of Diagnostic Radioisotopes, Established Date
- 3.9 Global Diagnostic Radioisotopes Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 China Isotope & Radiation
- 4.1.1 China Isotope & Radiation Company Information
- 4.1.2 China Isotope & Radiation Business Overview
- 4.1.3 China Isotope & Radiation Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 China Isotope & Radiation Diagnostic Radioisotopes Product Portfolio
- 4.1.5 China Isotope & Radiation Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Diagnostic Radioisotopes Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Eli Lilly
- 4.3.1 Eli Lilly Company Information
- 4.3.2 Eli Lilly Business Overview
- 4.3.3 Eli Lilly Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Eli Lilly Diagnostic Radioisotopes Product Portfolio
- 4.3.5 Eli Lilly Recent Developments
- 4.4 Dongcheng
- 4.4.1 Dongcheng Company Information
- 4.4.2 Dongcheng Business Overview
- 4.4.3 Dongcheng Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Dongcheng Diagnostic Radioisotopes Product Portfolio
- 4.4.5 Dongcheng Recent Developments
- 4.5 SIEMENS
- 4.5.1 SIEMENS Company Information
- 4.5.2 SIEMENS Business Overview
- 4.5.3 SIEMENS Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 SIEMENS Diagnostic Radioisotopes Product Portfolio
- 4.5.5 SIEMENS Recent Developments
- 4.6 Lantheus
- 4.6.1 Lantheus Company Information
- 4.6.2 Lantheus Business Overview
- 4.6.3 Lantheus Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Lantheus Diagnostic Radioisotopes Product Portfolio
- 4.6.5 Lantheus Recent Developments
- 4.7 Jubilant Pharma
- 4.7.1 Jubilant Pharma Company Information
- 4.7.2 Jubilant Pharma Business Overview
- 4.7.3 Jubilant Pharma Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Jubilant Pharma Diagnostic Radioisotopes Product Portfolio
- 4.7.5 Jubilant Pharma Recent Developments
- 4.8 GE Healthcare
- 4.8.1 GE Healthcare Company Information
- 4.8.2 GE Healthcare Business Overview
- 4.8.3 GE Healthcare Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 GE Healthcare Diagnostic Radioisotopes Product Portfolio
- 4.8.5 GE Healthcare Recent Developments
- 4.9 Curium Pharma
- 4.9.1 Curium Pharma Company Information
- 4.9.2 Curium Pharma Business Overview
- 4.9.3 Curium Pharma Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Curium Pharma Diagnostic Radioisotopes Product Portfolio
- 4.9.5 Curium Pharma Recent Developments
- 4.10 Cardinal Health
- 4.10.1 Cardinal Health Company Information
- 4.10.2 Cardinal Health Business Overview
- 4.10.3 Cardinal Health Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Cardinal Health Diagnostic Radioisotopes Product Portfolio
- 4.10.5 Cardinal Health Recent Developments
- 4.11 Bracco Imaging
- 4.11.1 Bracco Imaging Company Information
- 4.11.2 Bracco Imaging Business Overview
- 4.11.3 Bracco Imaging Diagnostic Radioisotopes Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Bracco Imaging Diagnostic Radioisotopes Product Portfolio
- 4.11.5 Bracco Imaging Recent Developments
5 Global Diagnostic Radioisotopes Market Scenario by Region
- 5.1 Global Diagnostic Radioisotopes Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Diagnostic Radioisotopes Sales by Region: 2021-2032
- 5.2.1 Global Diagnostic Radioisotopes Sales by Region: 2021-2026
- 5.2.2 Global Diagnostic Radioisotopes Sales by Region: 2027-2032
- 5.3 Global Diagnostic Radioisotopes Revenue by Region: 2021-2032
- 5.3.1 Global Diagnostic Radioisotopes Revenue by Region: 2021-2026
- 5.3.2 Global Diagnostic Radioisotopes Revenue by Region: 2027-2032
- 5.4 North America Diagnostic Radioisotopes Market Facts & Figures by Country
- 5.4.1 North America Diagnostic Radioisotopes Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Diagnostic Radioisotopes Sales by Country (2021-2032)
- 5.4.3 North America Diagnostic Radioisotopes Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Diagnostic Radioisotopes Market Facts & Figures by Country
- 5.5.1 Europe Diagnostic Radioisotopes Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Diagnostic Radioisotopes Sales by Country (2021-2032)
- 5.5.3 Europe Diagnostic Radioisotopes Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Diagnostic Radioisotopes Market Facts & Figures by Country
- 5.6.1 Asia Pacific Diagnostic Radioisotopes Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Diagnostic Radioisotopes Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Diagnostic Radioisotopes Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Diagnostic Radioisotopes Market Facts & Figures by Country
- 5.7.1 South America Diagnostic Radioisotopes Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Diagnostic Radioisotopes Sales by Country (2021-2032)
- 5.7.3 South America Diagnostic Radioisotopes Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Diagnostic Radioisotopes Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Diagnostic Radioisotopes Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Diagnostic Radioisotopes Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Diagnostic Radioisotopes Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Diagnostic Radioisotopes Sales by Type (2021-2032)
- 6.1.1 Global Diagnostic Radioisotopes Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Diagnostic Radioisotopes Sales Market Share by Type (2021-2032)
- 6.2 Global Diagnostic Radioisotopes Revenue by Type (2021-2032)
- 6.2.1 Global Diagnostic Radioisotopes Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Diagnostic Radioisotopes Revenue Market Share by Type (2021-2032)
- 6.3 Global Diagnostic Radioisotopes Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Diagnostic Radioisotopes Sales by Application (2021-2032)
- 7.1.1 Global Diagnostic Radioisotopes Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Diagnostic Radioisotopes Sales Market Share by Application (2021-2032)
- 7.2 Global Diagnostic Radioisotopes Revenue by Application (2021-2032)
- 7.2.1 Global Diagnostic Radioisotopes Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Diagnostic Radioisotopes Revenue Market Share by Application (2021-2032)
- 7.3 Global Diagnostic Radioisotopes Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Diagnostic Radioisotopes Value Chain Analysis
- 8.1.1 Diagnostic Radioisotopes Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Diagnostic Radioisotopes Production Mode & Process
- 8.2 Diagnostic Radioisotopes Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Diagnostic Radioisotopes Distributors
- 8.2.3 Diagnostic Radioisotopes Customers
9 Global Diagnostic Radioisotopes Analyzing Market Dynamics
- 9.1 Diagnostic Radioisotopes Industry Trends
- 9.2 Diagnostic Radioisotopes Industry Drivers
- 9.3 Diagnostic Radioisotopes Industry Opportunities and Challenges
- 9.4 Diagnostic Radioisotopes Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst